Chronix Biomedical - applies proprietary techniques that utilize serum DNA to develop routine blood tests for the early detection and management of cancer.Chronix Biomedical is pioneering a breakthrough approach to the diagnosis and management of cancer. It has developed proprietary blood tests that measure unique cancer DNA sequences. The Company is focused on blood tests for breast and prostate cancer. In-house validation tests have shown that these new genetic tests can outperform the existing gold standards.
Chronix is headquartered in San Jose, California and has a research facility in Germany.
